Enko is a crop health company that discovers and develops novel products for farmers to protect their crops from pests and disease.
Enko designs safe and sustainable solutions to farmers’ biggest crop threats today, from pest resistance to new diseases.
Enko Chem was founded in 2017 by Jacqueline Heard. The company is headquartered in Mystic, Connecticut.
Enko created ENKOMPASSTM technology platform, which combines DNA-encoded library screening with machine learning and structure-based design to quickly find new, better performing and more targeted chemistries.
Enko has generated hundreds of leading molecules across all categories of crop protection. Enko's product pipeline is currently led by a range of herbicides that are demonstrating breakthrough performance compared to industry standards like glyphosate.
Enko is collaborating with Bayer, Syngenta, and Nufarm, on promising new chemistries. Enko's target-based approach has generated its industry-leading discoveries in roughly half the time and with fewer resources than conventional R&D methods.
Enko is backed by Bill & Melinda Gates Foundation, Nufarm, Anterra Capital, Rabo Food & Agri Innovation Fund, Finistere Ventures, Novalis LifeSciences, Eight Roads Ventures, Endeavor8, Germin8 Ventures, Akroyd, and others. The company raised an additional $10M in Series C round on Jan 31, 2023. This is an extension of of its previous $70M raised in Jul 2022, bringing the Series C total to $80M. The additional investment brings Enko's overall funding to $134.7M to date.